États-Unis · Plateformes & données · Finviz

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Publié par Finviz · États-Unis il y a 23 h

Rapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing small molecule precision medicines for patients with neurological and…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

Rapport Therapeutics to Participate in Upcoming Investor Conferences

À lire aussi

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Jack Dorsey-led Block’s DOJ settlement overshadows Q3 profit

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Partager

À lire aussi

Moderna says Ebola vaccine picked for Phase 2/3 trial in Africa

Why Palantir Technologies Stock Dropped Today

Medicare prescription drug costs will jump 50% in 2027. Doing nothing could cost you.

10-year Treasury yield is little changed as traders mull over Democrats' midterm victories

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Jack Dorsey-led Block’s DOJ settlement overshadows Q3 profit